Contents hide 1 About Letermovir 2 Adult 2.1 Cytomegalovirus Infection Prophylaxis in HSCT 2.2 Cytomegalovirus Disease Prophylaxis in Kidney Transplant Recipients 2.3 Dosage Modifications 2.3.1 Coadministration with cyclosporine 2.3.2 Renal impairment 2.3.3 Hepatic impairment 2.4 Dosing Considerations 3 Pediatric 3.1 Cytomegalovirus infection prophylaxis in HSCT 3.1.1 >12 years 3.1.2 >=6 years: 3.2 Cytomegalovirus disease prophylaxis in kidney transplant recipients 3.2.1 >12 years 3.2.2 >=6 years: 3.3 Dosage modifications 3.3.1 Coadministration with cyclosporine in HSCT patients (>=12 years and >=30 kg) and kidney transplant (>=12 years and >=40 kg) 3.3.2 Co-administered with cyclosporine in HSCT recipients 6 Months to <12 years … Continue reading Generic (Letermovir) LETEDX